Lifeng Wang

1.1k total citations
44 papers, 754 citations indexed

About

Lifeng Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lifeng Wang has authored 44 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Lifeng Wang's work include Lung Cancer Treatments and Mutations (10 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Lifeng Wang is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Lifeng Wang collaborates with scholars based in China, United States and Canada. Lifeng Wang's co-authors include Baorui Liu, Jia Wei, Rutian Li, Lixia Yu, Xiaoping Qian, Haitao Yin, Hanqing Qian, Lianru Zhang, Shu Su and Yang Zhao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Agricultural and Food Chemistry.

In The Last Decade

Lifeng Wang

37 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lifeng Wang China 15 334 230 186 166 136 44 754
Xu He China 19 358 1.1× 213 0.9× 143 0.8× 281 1.7× 197 1.4× 49 912
Hongzhuan Yin China 19 539 1.6× 115 0.5× 164 0.9× 253 1.5× 144 1.1× 35 915
Huajun Zhang China 9 364 1.1× 200 0.9× 122 0.7× 153 0.9× 147 1.1× 18 896
Qianqian Yu China 21 552 1.7× 218 0.9× 92 0.5× 98 0.6× 184 1.4× 37 1.0k
Mengxiong Sun China 19 482 1.4× 181 0.8× 237 1.3× 199 1.2× 142 1.0× 45 1.0k
Qiang Tong China 19 554 1.7× 182 0.8× 145 0.8× 219 1.3× 69 0.5× 63 917
Ezia Bello Italy 17 411 1.2× 287 1.2× 223 1.2× 140 0.8× 44 0.3× 36 922
Hegen Li China 14 256 0.8× 190 0.8× 159 0.9× 109 0.7× 132 1.0× 44 653

Countries citing papers authored by Lifeng Wang

Since Specialization
Citations

This map shows the geographic impact of Lifeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifeng Wang more than expected).

Fields of papers citing papers by Lifeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifeng Wang. The network helps show where Lifeng Wang may publish in the future.

Co-authorship network of co-authors of Lifeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lifeng Wang. A scholar is included among the top collaborators of Lifeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifeng Wang. Lifeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Ye, Xin Lv, Fufeng Wang, et al.. (2025). Predictive and prognostic value of genetic aberrations of EGFR-TKI treatment: a real-world analysis of EGFR-mutant non-small cell lung cancer. Journal of Thoracic Disease. 17(10). 8978–8991.
2.
Pan, Szu‐Yu, Chaochao Xiong, Jiahe Tian, et al.. (2025). MicroRNA-126-3p as a predictive biomarker for patients with primary biliary cholangitis refractory to ursodeoxycholic acid. World Journal of Gastroenterology. 31(31). 109828–109828.
3.
Chu, Yanhong, Lifeng Wang, Yaohua Ke, et al.. (2024). A multifunctional mesoporous silica drug delivery nanosystem that ameliorates tumor hypoxia and increases radiotherapy efficacy. NPG Asia Materials. 16(1). 5 indexed citations
4.
Su, Shu, Xin Lv, Wei Ming, et al.. (2024). Predictive value of peripheral blood biomarkers in patients with non-small-cell lung cancer responding to anti-PD-1-based treatment. Cancer Immunology Immunotherapy. 73(1). 12–12. 6 indexed citations
5.
6.
Zhang, Hanxi, Xiaolu Wang, Xin Lv, et al.. (2023). A series of nine newly developed techniques in CT-guided percutaneous lung biopsyPreliminary results from a prospective study.. Journal of Clinical Oncology. 41(16_suppl). e21023–e21023. 1 indexed citations
7.
Xing, Ligang, Yueyin Pan, Yuankai Shi, et al.. (2020). Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study. Clinical Cancer Research. 26(23). 6168–6175. 28 indexed citations
8.
Shen, Jie, Ling Yuan, Yang Yan, et al.. (2020). A novel device to capture circulating tumor cells: Quantification and molecular analysis in lung cancer patients. Journal of Biomaterials Applications. 35(1). 49–58. 2 indexed citations
9.
Liu, Fangcen, Lifeng Wang, Chen Xie, et al.. (2020). <p>Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells</p>. International Journal of Nanomedicine. Volume 15. 1283–1295. 27 indexed citations
10.
Lu, Yingjie, Xian Lu, Lifeng Wang, & Wei Yang. (2018). Resveratrol attenuates high fat diet-induced mouse cardiomyopathy through upregulation of estrogen related receptor-α. European Journal of Pharmacology. 843. 88–95. 21 indexed citations
11.
Zhang, Lianru, Rutian Li, Hong Chen, et al.. (2017). Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer. International Journal of Nanomedicine. Volume 12. 2129–2142. 117 indexed citations
12.
Wang, Lifeng, Yingjie Lu, Xian Liu, & Xiaoyun Wang. (2017). Ghrelin protected neonatal rat cardiomyocyte against hypoxia/reoxygenation injury by inhibiting apoptosis through Akt-mTOR signal. Molecular Biology Reports. 44(2). 219–226. 14 indexed citations
13.
Yang, Yang, Biao Zhang, Rutian Li, Baorui Liu, & Lifeng Wang. (2016). EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literature. Oncology Letters. 11(5). 3546–3550. 12 indexed citations
14.
Yin, Haitao, Yun Zhou, Chong Zhou, et al.. (2014). Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling. Oncology Reports. 32(4). 1610–1616. 70 indexed citations
15.
Wang, Lifeng, et al.. (2012). Preparation, Pharmacokinetics, and Tissue Distribution Properties of Icariin-Loaded Stealth Solid Lipid Nanoparticles in Mice. Chinese Herbal Medicines. 4(2). 170–174. 10 indexed citations
16.
Qian, Xiaoping, Lijing Zhu, Jing Hu, et al.. (2012). Rhizoma Paridis ethanol extract selectively inhibits the proliferation of HUVECs comparing to Lovo cells and shows anti-angiogenesis effects in a mouse model. Journal of Ethnopharmacology. 143(1). 256–261. 8 indexed citations
17.
Xie, Li, Xi Chen, Lifeng Wang, et al.. (2010). Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions. BMC Cancer. 10(1). 591–591. 39 indexed citations
18.
Wang, Tingting, Xiaoping Qian, Zhongqiu Wang, et al.. (2009). Detection of cell‐free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions. International Journal of Cancer. 125(8). 1921–1925. 19 indexed citations
19.
Wang, Lifeng, Jia Wei, Xiaoping Qian, et al.. (2008). ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel. BMC Cancer. 8(1). 97–97. 81 indexed citations
20.
Zhang, Wei, et al.. (2003). Immunohistochemical analysis of cyclooxygenase-2 expression in premalignant and malignant esophageal glandular and squamous lesions in Cixian, China. Cancer Detection and Prevention. 27(4). 243–249. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xu He Breakdown of academic impact, for papers by Hongzhuan Yin Breakdown of academic impact, for papers by Huajun Zhang Breakdown of academic impact, for papers by Qianqian Yu Breakdown of academic impact, for papers by Mengxiong Sun Breakdown of academic impact, for papers by Qiang Tong Breakdown of academic impact, for papers by Ezia Bello Breakdown of academic impact, for papers by Hegen Li
Rankless by CCL
2026